Cellulase-assisted platelet-rich plasma release from nanofibrillated cellulose hydrogel enhances wound healing

Elle Koivunotko, Raili Koivuniemi, Julia Monola, Riina Harjumäki, Chris S. Pridgeon, Mari Madetoja, Jere Linden, Lauri Paasonen, Saara Laitinen, Marjo Yliperttula

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Sammanfattning

Platelet-rich plasma (PRP) is a source of growth factors, which are implicated in active tissue regeneration. However, after transplantation the efficacy of these bioactive compounds is often diminished due to rapid degradation and untargeted localization. For this reason, we evaluated the potential of nanofibrillated cellulose (NFC) hydrogel as a PRP carrier. NFC hydrogel is an animal-free biomaterial that, when doped with cellulase, can assist the release of PRP in a wound site. In this study, we examined the effects of 0.5% (m/v) NFC hydrogel formulations, including PRP and cellulase, on the migration and proliferation of skin cells via an in vitro scratch wound model. The suitability of the 0.8% NFC hydrogel formulations for accelerated wound healing and PRP carrying was studied in vitro in diffusion studies and in vivo in a full-thickness excisional wound model in SKH1 mice. None of the NFC hydrogel formulations with or without PRP and cellulase disturbed the normal cell behavior in vitro, and cellulase was successfully used to degrade NFC. NFC hydrogel slowed fibroblast migration rate in vitro. In vivo, NFC hydrogel treatment showed significantly enhanced re-epithelialization compared to control and supported collagen deposition. In addition, angiogenesis was significantly induced via PRP release after degrading NFC hydrogel with cellulase without abnormal host reaction. This study demonstrates the potential of NFC hydrogel with cellulase as a carrier for PRP with controlled release in future skin tissue engineering applications.

Originalspråkengelska
TidskriftJournal of Controlled Release
Volym368
Sidor (från-till)397-412
Antal sidor16
ISSN0168-3659
DOI
StatusPublicerad - apr. 2024
MoE-publikationstypA1 Tidskriftsartikel-refererad

Bibliografisk information

Publisher Copyright:
© 2024

Vetenskapsgrenar

  • 317 Farmaci

Citera det här